A new trading day began on Friday, with Vaxcyte Inc (NASDAQ: PCVX) stock price down -4.85% from the previous day of trading, before settling in for the closing price of $74.81. PCVX’s price has ranged from $58.10 to $121.06 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -18.98%. With a float of $125.00 million, this company’s outstanding shares have now reached $128.76 million.
The firm has a total of 414 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Vaxcyte Inc (PCVX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Vaxcyte Inc is 2.92%, while institutional ownership is 107.86%. The most recent insider transaction that took place on Mar 05 ’25, was worth 353,699. In this transaction SVP, GEN COUNSEL & CORP SEC of this company sold 5,000 shares at a rate of $70.74, taking the stock ownership to the 41,620 shares. Before that another transaction happened on Mar 05 ’25, when Company’s Officer proposed sale 5,000 for $68.87, making the entire transaction worth $344,350.
Vaxcyte Inc (PCVX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.97 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -18.98% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -5.58% during the next five years compared to -29.88% drop over the previous five years of trading.
Vaxcyte Inc (NASDAQ: PCVX) Trading Performance Indicators
Here are Vaxcyte Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 12.75.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.88, a number that is poised to hit -1.04 in the next quarter and is forecasted to reach -4.64 in one year’s time.
Technical Analysis of Vaxcyte Inc (PCVX)
Analysing the last 5-days average volume posted by the [Vaxcyte Inc, PCVX], we can find that recorded value of 1.5 million was better than the volume posted last year of 1.2 million. As of the previous 9 days, the stock’s Stochastic %D was 27.58%. Additionally, its Average True Range was 3.82.
During the past 100 days, Vaxcyte Inc’s (PCVX) raw stochastic average was set at 3.67%, which indicates a significant decrease from 11.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.66% in the past 14 days, which was lower than the 46.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $83.48, while its 200-day Moving Average is $89.13. Now, the first resistance to watch is $73.80. This is followed by the second major resistance level at $76.42. The third major resistance level sits at $77.77. If the price goes on to break the first support level at $69.84, it is likely to go to the next support level at $68.49. Now, if the price goes above the second support level, the third support stands at $65.87.
Vaxcyte Inc (NASDAQ: PCVX) Key Stats
With a market capitalization of 9.17 billion, the company has a total of 128,762K Shares Outstanding. Currently, annual sales are 0 K while annual income is -463,930 K. The company’s previous quarter sales were 0 K while its latest quarter income was -137,080 K.
